Suppression of Glutamine:Fructose-6-phosphate amidotransferase-1 inhibits adipogenesis in 3T3-L1 adipocytes

Journal of Cellular Physiology

Volumn 227, Issue 1, 2012, Pages 108-115

  Hsieh, Tusty Jiuan ^a   Lin, Tzu ^a   Hsieh, Pei Chen ^a   Liao, Min Chun ^a   Shin, Shyi Jang ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOPHILIN; CCAAT ENHANCER BINDING PROTEIN BETA; DEXAMETHASONE; FAT DROPLET; FATTY ACID SYNTHASE; GLUCOSE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMIDOTRANSFERASE 1; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; INSULIN; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; N ACETYLGLUCOSAMINE; PERILIPIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SMALL INTERFERING RNA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; AMINOACYLATION; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; UPREGULATION;

ACETYLATION; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUTAMINE; IMMUNOPRECIPITATION; MICE; NITROGENOUS GROUP TRANSFERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 80054911289     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22707     Document Type: Article

References (32)

1. Brasaemle DL. 2007. The perilipin family of structural lipid droplet proteins: Stabilization of lipid droplets and control of lipolysis. J Lipid Res 48:2547-2559.
2. Buse MG. 2006. Hexosamines, insulin resistance, and the complications of diabetes: Current status. Am J Physiol Endocrinol Metab 290:E1-E8.
3. Copeland RJ, Bullen JW, Hart GW. 2008. Cross-talk between GlcNAcylation and phosphorylation: Roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab 295:E17-E28.
4. Dehennaut V, Lefebvre T, Sellier C, Leroy Y, Gross B, Walker S, Cacan R, Michalski JC, Vilain JP, Bodart JF. 2007. O-linked N-acetylglucosaminyltransferase inhibition prevents G2/M transition in Xenopus laevis oocytes. J Biol Chem 282:12527-12536.
5. Dehennaut V, Lefebvre T, Leroy Y, Vilain JP, Michalski JC, Bodart JF. 2009. Survey of O-GlcNAc level variations in Xenopus laevis from oogenesis to early development. Glycoconj J 26:301-311.
6. Dubois SG, Heilbronn LK, Smith SR, Albu JB, Kelley DE, Ravussin E. 2006. Decreased expression of adipogenic genes in obese subjects with type 2 diabetes. Obesity (Silver Spring) 14:1543-1552.
7. Farmer SR. 2006. Transcriptional control of adipocyte formation. Cell Metab 4:263-273.
8. Federici M, Menghini R, Mauriello A, Hribal ML, Ferrelli F, Lauro D, Sbraccia P, Spagnoli LG, Sesti G, Lauro R. 2002. Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation 106:466-472.
9. Gregoire FM, Smas CM, Sul HS. 1998. Understanding adipocyte differentiation. Physiol Rev 78:783-809.
10. Guilherme A, Virbasius JV, Puri V, Czech MP. 2008. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9:367-377.
11. Hanover JA. 2001. Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J 15:1865-1876.
12. Hebert LF, Daniels MC, Zhou J, Crook ED, Turner RL, Simmons ST, Neidigh JL, Zhu JS, Baron AD, McClain DA. 1996. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 98:930-936.
13. Ishihara K, Takahashi I, Tsuchiya Y, Hasegawa M, Kamemura K. 2010. Characteristic increase in nucleocytoplasmic protein glycosylation by O-GlcNAc in 3T3-L1 adipocyte differentiation. Biochem Biophys Res Commun 398:489-494.
14. Kersten S. 2001. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2:282-286.
15. Kinkel AD, Fernyhough ME, Helterline DL, Vierck JL, Oberg KS, Vance TJ, Hausman GJ, Hill RA, Dodson MV. 2004. Oil red-O stains non-adipogenic cells: A precautionary note. Cytotechnology 46:49-56.
16. Li X, Molina H, Huang H, Zhang YY, Liu M, Qian SW, Slawson C, Dias WB, Pandey A, Hart GW, Lane MD, Tang QQ. 2009. O-linked N-acetylglucosamine modification on CCAAT enhancer-binding protein beta: Role during adipocyte differentiation. J Biol Chem 284:19248-19254.
17. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV, Ory DS, Schaffer JE. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Curr Opin Lipidol 3:281-287.
18. Luo B, Parker GJ, Cooksey RC, Soesanto Y, Evans M, Jones D, McClain DA. 2007. Chronic hexosamine flux stimulates fatty acid oxidation by activating AMP-activated protein kinase in adipocytes. J Biol Chem 282:7172-7180.
19. Macauley MS, Bubb AK, Martinez-Fleites C, Davies GJ, Vocadlo DJ. 2008. Elevation of global O-GlcNAc levels in 3T3-L1 adipocytes by selective inhibition of O-GlcNAcase does not induce insulin resistance. J Biol Chem 283:34687-34695.
20. Matsuzawa Y. 2005. Adipocytokines and metabolic syndrome. Semin Vasc Med 5:34-39.
21. McClain DA, Hazel M, Parker G, Cooksey RC. 2005. Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid. Am J Physiol Endocrinol Metab 288:E973-E979.
22. Miura S, Gan JW, Brzostowski J, Parisi MJ, Schultz CJ, Londos C, Oliver B, Kimmel AR. 2002. Functional conservation for lipid storage droplet association among Perilipin, ADRP, and TIP47 (PAT)-related proteins in mammals, Drosophila, and Dictyostelium. J Biol Chem 277:32253-32257.
23. Ntambi JM, Kim YC. 2000. Adipocyte differentiation and gene expression. J Nutr 130:3122S-3126S.
24. Robinson KA, Ball LE, Buse MG. 2007. Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 292:E884-E890.
25. Selvarajan S, Lund LR, Takeuchi T, Craik CS, Werb Z. 2001. A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol 3:267-275.
26. Teo CF, Wollaston-Hayden EE, Wells L. 2010. Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytes. Mol Cell Endocrinol 318:44-53.
27. Vazquez-Vela MEF, Torres N, Tovar AR. 2008. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 39:715-728.
28. Van den Steen P, Rudd PM, Dwek RA, Openakker G. 1998. Concepts and principles of O-linked glycosylation. Crit Rev Biochem Mol Biol 33:151-208.
29. Vosseller K, Wells L, Lane MD, Hart GW. 2002. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci USA 99:5313-5318.
30. Weigert C, Thamer C, Brodbeck K, Guirguis A, Machicao F, Machann J, Schick F, Stumvoll M, Fritsche A, Häring HU, Schleicher ED. 2005. The -913 G/A glutamine:fructose-6-phosphate aminotransferase gene polymorphism is associated with measures of obesity and intramyocellular lipid content in nondiabetic subjects. J Clin Endocrinol Metab 90:1639-1643.
31. Wells L, Hart GW. 2003. O-GlcNAc turns twenty. FEBS Lett 546:154-158.
32. Yki-Järvinen H, Virkamäki A, Daniels MC, McClain D, Gottschalk WK. 1998. Insulin and glucosamine infusions increase O-linked N-acetylglucosamine in skeletal muscle proteins in vivo. Metabolism 47:449-455.